Agilent acquires Stratagene
Agilent Technologies has announced the acquisition of the company Stratagene, effective as of today.
The takeover is hoped to assist the company in providing more complete workflow solutions in genomics, proteomics and metabolomics.
Stratagene will operate as a division of the company's Life Sciences Solutions unit.
The company has said current customers should expect no change in the way they work with Stratagene and should be able to continue using their existing contact channels.
$492m pathology hub coming to Westmead Health Precinct
The NSW Health Pathology Statewide Hub will be delivered to Westmead Health Precinct, as part of...
WA Govt appoints Sharath Sriram as Chief Scientist
A distinguished science and research leader with 20 years of experience in science and...
$50m donation for new endometriosis research institute
Three generations of the philanthropic Ainsworth family have committed a total of $50 million...
